malondialdehyde has been researched along with valsartan in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Chowdhury, NA; Cooper, SA; Ferrario, C; Gallagher, PE; Habibi, J; Hayden, MR; Link, CD; Sowers, JR; Stump, CS; Tallant, EA; Whaley-Connell, AT; Wiedmeyer, CE | 1 |
| Durante, A; Monacelli, F; Odetti, P; Poggi, A; Storace, D; Traverso, N; Viviani, GL | 1 |
| Chen, S; Huang, H; Li, R; Liu, P; Tang, F; Wang, P; Zhang, H | 1 |
| Akhter, N; Alom, MM; Bhuiyan, NI; Rozario, RJ | 1 |
| Cheng, YN; Gao, JJ; Jiao, B; Wang, YS; Zhang, QZ | 1 |
| Chen, C; Dai, R; Hong, M; Lin, R; Wu, B; Wu, H | 1 |
| Feng, GF; Han, H; Hu, XD; Liu, Y; Qian, YH; Shi, LL; Yang, WN | 1 |
| Argani, H; Bargahi, N; Dastmalchi, S; Ghasemi, B; Ghazizadeh, T; Ghorbanihaghjo, A; Mesgari Abbasi, M; Mota, A; Nemati, M; Raeisi, S; Rashtchizadeh, N; Vatankhah, AM | 1 |
| Akhtar, M; Akhtar, MS; Hassan, MQ; Imran, M; Najmi, AK; Rahman, O | 1 |
| Bian, Q; Guo, L; Liang, T; Liu, J; Luo, B; Niu, J; Song, Q; Wei, Q; Zhang, K | 1 |
| Gao, A; Gao, X; Tian, W; Wang, Y | 1 |
11 other study(ies) available for malondialdehyde and valsartan
| Article | Year |
|---|---|
Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Animals, Genetically Modified; Blood Pressure; Disease Models, Animal; Hypertension, Renal; Kidney Glomerulus; Male; Malondialdehyde; Mice; Microscopy, Electron, Transmission; NADPH Oxidases; Neprilysin; Oxidative Stress; Peptidyl-Dipeptidase A; Podocytes; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Valine; Valsartan | 2006 |
Effects of valsartan therapy on protein glycoxidation.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Arginine; Dinoprost; Female; Glycation End Products, Advanced; Glycosylation; Humans; Hypertension; Lysine; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Proteins; Tetrazoles; Valine; Valsartan | 2006 |
Contribution of different Nox homologues to cardiac remodeling in two-kidney two-clip renovascular hypertensive rats: effect of valsartan.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Cardiomegaly; Disease Models, Animal; Fibrosis; Heart Ventricles; Hypertension, Renovascular; Ligation; Male; Malondialdehyde; Membrane Glycoproteins; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Rats; Rats, Sprague-Dawley; Renal Artery; Superoxides; Tetrazoles; Valine; Valsartan; Ventricular Function, Left; Ventricular Remodeling | 2007 |
Antioxidant effect of valsartan in experimental model of myocardial infarction.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aspartate Aminotransferases; Creatine Kinase, MB Form; Epinephrine; Erythrocytes; Female; Glutathione; Male; Malondialdehyde; Models, Animal; Myocardial Infarction; Oxidative Stress; Rats; Tetrazoles; Valine; Valsartan | 2011 |
Valsartan attenuated oxidative stress, decreased MCP-1 and TGF-β1 expression in glomerular mesangial and epithelial cells induced by high-glucose levels.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Cell Culture Techniques; Cells, Cultured; Chemokine CCL2; Culture Media; Diabetic Nephropathies; Epithelial Cells; Glucose; Glutathione; Malondialdehyde; Mesangial Cells; Oxidative Stress; Rats; Reactive Oxygen Species; Superoxide Dismutase; Tetrazoles; Transforming Growth Factor beta1; Valine; Valsartan | 2011 |
Valsartan attenuates oxidative stress and NF-κB activation and reduces myocardial apoptosis after ischemia and reperfusion.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Caspase 3; Male; Malondialdehyde; Myocardial Reperfusion Injury; NADPH Oxidases; NF-kappa B; Oxidative Stress; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Tetrazoles; Tumor Necrosis Factor-alpha; Valine; Valsartan | 2013 |
The effects of valsartan on cognitive deficits induced by aluminum trichloride and d-galactose in mice.
Topics: Acetylcholinesterase; Aluminum Chloride; Aluminum Compounds; Animals; Cerebral Cortex; Chlorides; Cognition Disorders; Dementia; Disease Models, Animal; Galactose; Glutathione Peroxidase; Hippocampus; Malondialdehyde; Maze Learning; Memory Disorders; Mice; Nootropic Agents; Oxidative Stress; Random Allocation; Superoxide Dismutase; Tetrazoles; Valine; Valsartan | 2014 |
Effects of Angiotensin II Receptor Blockade on Soluble Klotho and Oxidative Stress in Calcineurin Inhibitor Nephrotoxicity in Rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Angiotensin Receptor Antagonists; Animals; Calcineurin Inhibitors; Cyclosporine; Deoxyguanosine; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Glucuronidase; Kidney; Kidney Diseases; Klotho Proteins; Malondialdehyde; Oxidative Stress; Random Allocation; Rats; Rats, Sprague-Dawley; Spectrophotometry; Valsartan | 2016 |
Sacubitril and valsartan protect from experimental myocardial infarction by ameliorating oxidative damage in Wistar rats.
Topics: Alanine Transaminase; Alkaline Phosphatase; Aminobutyrates; Animals; Antihypertensive Agents; Antioxidants; Aspartate Aminotransferases; Biphenyl Compounds; Catalase; Creatine Kinase, MB Form; Drug Combinations; Glutathione Peroxidase; Glutathione Reductase; Glutathione Transferase; Isoproterenol; Lactate Dehydrogenases; Male; Malondialdehyde; Myocardial Infarction; Myocardium; Neprilysin; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase; Tetrazoles; Valsartan | 2019 |
The probable roles of valsartan in alleviating chronic obstructive pulmonary disease following co-exposure to cold stress and fine particulate matter.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Angiotensin II Type 1 Receptor Blockers; Animals; Cold Temperature; Deoxyguanosine; Disease Models, Animal; Gene Expression Regulation; Heme Oxygenase-1; Humans; Male; Malondialdehyde; NF-kappa B; Particulate Matter; Pulmonary Disease, Chronic Obstructive; Rats; Tumor Necrosis Factor-alpha; Valsartan | 2018 |
LCZ696 ameliorates lipopolysaccharide-induced endothelial injury.
Topics: Aminobutyrates; Biphenyl Compounds; Cytokines; Drug Combinations; Human Umbilical Vein Endothelial Cells; Humans; Lipopolysaccharides; Malondialdehyde; Oxidative Stress; Protective Agents; Reactive Oxygen Species; Signal Transduction; Valsartan; Vascular Cell Adhesion Molecule-1 | 2021 |